A qualified medical team that uses human-grade medications and conducts proper patient screening can significantly reduce the likelihood of serious adverse events
Kondo, K
Ogata, Z
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion
/ $49) coming soon on PerriconeMD.com, Nordstrom.com, www.ECScottGroup.com, www.Bloomingdales.com, www.NeimanMarcus.com, LovelySkin.com, www.Macys.com, and www.Amazon.com
The peptide market has seen an influx of new vendors over the past 24 months, many with minimal track records and questionable quality standards
